EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.23 | medicine | LPCAT3 may have potential as a therapeutic target for diseases, including atherosclerosis, non-alcoholic steatohepatitis, and carcinoma | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.23 | gene LPCAT3, recombinant expression of C-terminally Twin-Strep-tagged enzyme in Spodoptera frugiperda Sf9 cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.23 | TSI-10 | an LPCAT3 inhibitor | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.23 | additional information | - |
additional information | Km of NBD-lyso-PC and arachidonoyl CoA by the model of Bi-Bi reaction under optimal conditions. The theoretical Km values calculated by Bi-Bi kinetic equations are more accurate than that calculated by the Michaelis-Menten equation because the apparent Km of one substrate calculated by the Michaelis-Menten equation may be influenced by the concentration of another, whereas Bi-Bi kinetic equations could overcome this disadvantage. From the Lineweaver-Burk plots, a sequential kinetic mechanism can be proposed, but only a sequential Bi-Bi kinetic mechanism can be infered | Homo sapiens | |
2.3.1.23 | 0.011 | - |
Arachidonoyl-CoA | pH 6.0, 30°C, recombinant enzyme | Homo sapiens | |
2.3.1.23 | 0.2668 | - |
NBD-labelled lysophosphatidylcholine | pH 6.0, 30°C, recombinant enzyme | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.3.1.23 | membrane | - |
Homo sapiens | 16020 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.23 | Homo sapiens | Q6P1A2 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.1.23 | recombinant Twin-Strep-tagged enzyme from Sf9 insect cells by membrane preparation, affinity chromatography, and gel filtration | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.23 | arachidonoyl-CoA + NBD-labelled lysophosphatidylcholine | - |
Homo sapiens | CoA + NBD-2-arachidonoyl-phosphatidylcholine | - |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.23 | LPCAT3 | - |
Homo sapiens |
2.3.1.23 | LPLAT5 | - |
Homo sapiens |
2.3.1.23 | lysophosphatidylcholine acyltransferase 3 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.23 | 30 | - |
- |
Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.23 | 6 | - |
- |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.3.1.23 | 0.174 | - |
pH 6.0, 30°C, recombinant enzyme | Homo sapiens | TSI-10 |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.23 | physiological function | lysophosphatidylcholine acyltransferase 3 (LPCAT3) is an important enzyme in phospholipid remodeling, a process that influences the biophysical properties of cell membranes and thus cell function. LPCAT3 is involved in several diseases, including atherosclerosis, non-alcoholic steatohepatitis, and carcinoma | Homo sapiens |